CG Oncology (CGON) Market Cap & Net Worth - Stock Analysis

3 days ago · Stock Analysis Pro. Watchlist. ... History; Profile; Chart; Statistics; Market Cap; Revenue; CG Oncology Market Cap. CG Oncology has a market cap or net worth of $2.31 billion as of November 27, 2024. ... Mid-Cap. Stock Price $34.10. Market Cap Chart $ % Since the …

CouponFollow Extension

$2.31
OFF

CG Oncology (CGON) Market Cap & Net Worth - Stock Analysis

4 weeks from now

stockanalysis.com

6%
OFF

CG Oncology, Inc. (CGON) Stock Price, Quote & News - Stock …

4 weeks from now

5 days ago · CG Oncology CGON.O notched up a valuation of $1.75 billion in its market debut on Thursday, after shares of the cancer drug developer rose 52.6% at the open on the Nasdaq. …

stockanalysis.com

77%
OFF

CG Oncology Market Cap Insights | YCharts

4 weeks from now

In depth view into CG Oncology Market Cap including historical data from 2024, charts and stats. CG Oncology Inc (CGON) 33.69-0.26 (-0.77%) ... Historical Market Cap Data. View and export …

ycharts.com

$1.94
OFF

CG Oncology Stock Price | CGON Stock Quote, News, And History

4 weeks from now

The latest CG Oncology stock prices, stock quotes, news, and CGON history to help you invest and trade smarter. ... CG Oncology Inc Registered Shs's market capitalization is $1.94 B by …

businessinsider.com

5%
OFF

Cg Oncology Stock Price Today (NASDAQ: CGON) Quote, Market …

4 weeks from now

4 days ago · Net Income-$20.4M. Profit Margin-47,453.5%. ... (NASDAQ: CGON) Cg Oncology trades on the NASDAQ under the ticker symbol CGON. Cg Oncology stock quotes can also be …

wallstreetzen.com

97%
OFF

CG Oncology (CGON) Stock Price, News & Analysis - MarketBeat

4 weeks from now

Nov 22, 2024 · CG Oncology had a negative trailing twelve-month return on equity of 18.97% and a negative net margin of 10,642.98%. When did CG Oncology IPO? CG Oncology (CGON) …

marketbeat.com

FAQs about CG Oncology (CGON) Market Cap & Net Worth - Stock Analysis Coupon?

How much is CG oncology worth?

The company's lead drug targets a sizable addressa... CG Oncology CGON.O notched up a valuation of $1.75 billion in its market debut on Thursday, after shares of the cancer drug developer rose 52.6% at the open on the Nasdaq. ...

Is CG oncology a good IPO?

Biotech stocks have fallen about 1% so far this year. With a lead asset in advanced Phase-III testing, CG Oncology, which debuts Thursday on the NASDAQ, is one of the year's most highly anticipated IPOs. The company's lead drug targets a sizable addressa... ...

Will CG oncology raise $100 million in a public offering?

IRVINE, Calif.-- (BUSINESS WIRE)--CG Oncology Announces Pricing of Upsized Initial Public Offering. CG Oncology, a Phase 3 biotech developing an oncolytic immunotherapy for bladder cancer, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering. ...

What does CG oncology stand for?

IRVINE, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone blad... ...

Will CG Oncology GO Public?

The firm aims to list on the Nasdaq under the symbol CGON. CG Oncology has filed to go public with an IPO on the NASDAQ. CG Oncology has received fast track designation and breakthrough designation needed to accelerate US FDA submission. ...

Does cgon pay a dividend?

A company's dividend expressed as a percentage of its current stock price. CGON is not currently paying a regular dividend. The total number of shares of a security that have been sold short and not yet repurchased. Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month. ...